Embracing Disruption

Created in China: Humanoid Robots

Over recent years, much of the media attention on China has been related to macro challenges – geopolitical conflicts, the weakness of the property sector and deflationary pressures. In our view, this focus has distracted investors from the rapid pace of development in China’s technology space.

Indeed, US trade restrictions designed to prevent Chinese companies from sourcing high spec technology components, aimed at stifling Chinese innovation, have instead served to reinforce China’s push to become increasingly self-reliant in critical industries of the future. It is in this context that the launch in January of DeepSeek – China’s answer to ChatGPT – shocked the technology world.

But while the DeepSeek announcement has been widely publicised because of its impact on technology stocks around the world, there have been a number of additional signs pointing to China’s ‘under the radar’ progress. This piece, covering humanoid robots, is the first in a new series that will highlight China’s new areas of technological innovation. Over time, we believe that these will provide significant investment opportunities.

Humanoid robots – the next revolutionary technology?

Humanoid robots, unlike industrial robots, are designed to mimic humans in both form and function – machines capable of thinking and behaving like a real person. While commonly depicted in movies set in the distant future, significant investment and sooner-than-expected progress in artificial intelligence and hardware engineering have brought us closer to seeing humanoid robots integrated into everyday lives.

With a wide scope of application, humanoid robots have the potential to transform industries, boost productivity, and fundamentally redefine the way we interact with technology.

Humanoid robot development was popularized in 2021 when leading electric vehicle brand Tesla announced development plans for its general-purpose humanoid robot “Optimus”. Just four years later in January 2025, fourteen humanoid robot models from emerging industry leaders proudly stood on the stage at the Consumer Electronics Show (CES) in Las Vegas, the premier global technology trade exhibition. On the same stage, Jensen Huang, CEO of Nvidia, declared that “the ChatGPT moment for general robotics is just around the corner”, predicting Nvidia’s products to power a billion humanoid robots in the coming years1.

The total addressable market for humanoid robots is projected to reach USD 38 billion by 20352. There is a wide range of potential applications across various fields.

With time, humanoid robots could for example, evolve to perform surgeries with precision. As a first step in this direction, a Korean company has just received FDA approval in the US to use its robots in brain surgery3. In education they could serve as teaching assistants and provide support in classrooms. And in manufacturing, humanoid robots could work alongside people handling tasks that are repetitive, dangerous or require high precision. This is another field where we see further signs of progress – Amazon, the US online retailer has started testing the use of humanoid robots to move boxes and sort packages alongside human employees in distribution warehouses4.

And over time, functionalities that address the needs of the mass consumer market, such as a live-in housekeeper or a companion for the elderly, are expected to be to drivers for broader adoption.

China’s key role in the sector’s evolution

While much of the global spotlight related to humanoid robots so far has been on US-led developments, Chinese companies already play a critical role in the sector’s evolution as a provider of key components underlying robotic functions. This includes high precision sensors, control systems, motor parts, efficient battery solutions, and semiconductor technology.

With China’s deep industrial value chains and manufacturing advantages, the gap in product quality between Chinese-produced components and those made by US and Japan competitors has been narrowing. And as industry leaders race to bring humanoid robots to the mass-market, Chinese companies continue to provide the scale and cost advantages needed to bring humanoid robots to commercialization.

Holding around two-thirds of global robotics patents5, China has been the world’s largest market for industrial robots for over a decade6 and has made significant advancements in automation and autonomous technologies. This expertise in industrial robotics is the foundation for its clout in the emerging field of humanoid robotics. In fact, four out of the fourteen humanoid models that stood on stage with Jensen Huang a the 2025 CES event were developed by Chinese companies.

Beyond industrial settings and trade shows, robots have also started to become a more familiar presence in everyday lives in China. They can be found checking guests into hotels, delivering food to customer tables at hotpot restaurants, and even climbing the Great Wall of China alongside tourists.

Humanoid robots even made a recent appearance in the nation-wide Chinese Lunar New Year television broadcast, an annual spectacle drawing more than a billion viewers in China. During the four-hour program, humanoid robots took to the stage performing an intricately choreographed folk dance among professional dancers. A behind-thescenes video showed the robots carefully rehearsing dance steps, shaking hands, and posing for selfies7.

New technologies inevitably take time to become widely accepted and understood. However, China’s growing integration of smart applications into everyday life serves as an example of ways to bridge the gap between hardware engineering and humanfocused design that is at the center of humanoid robot applications.

Humanoid Robots

Source: AllianzGI, January 2025

Conclusion

In our view, China’s long-term economic objective is to build a future growth model based on technology-intensive manufacturing, and in so doing to reduce the previous reliance on property and infrastructure. Over time we expect that this will result in a more dynamic and diverse investment universe. Humanoid robots are just one area of innovation that investors may want to consider when investing in China’s future technologies.

Capturing investment opportunities related to humanoid robots

Already there are a number of listed companies that have invested significant capital and human resources to the development of humanoid robots. Examples include:

  • Zhejiang Shuanghuan Driveline – a producer of transmission systems used in automobiles and power electric systems that transform battery power into mechanical movement in robotic limbs. The company holds a portfolio of over 400 patents in power management, electric motor, and control algorithms design8.
  • Zhejiang Sanhua Intelligent Controls – a Chinese developer of motion and thermal control systems to enable smooth, precise movement in robots. The company currently supplies thermal management technology for Tesla’s electric vehicles and is expected to further this partnership and supply key components for Optimus, Tesla’s humanoid robot.
  • Cambricon Technologies – an AI chip designer in China with a focus on high-performance solutions for computer vision and language processing needed to efficiently develop and deploy AI models tailored for humanoid robots.

1 Ctech, as of 27 January 2025
2 Goldman Sachs, as of 8 January 2024
3 Korea Economic Daily, as of 21 January 2025
4 Bloomberg, as of 4 March 2024
5 International Federation of Robotics, as of 30 September 2023
6 China Briefing, as of 30 January 2025
7 SCMP, as of 4 February 2025
8 Zhejiang Shuanghuan Driveline company website, as of 10 February 2025

  • Disclaimer
    Investing involves risk. The value of an investment and the income from it will fluctuate and investors may not get back the principal invested. Past performance is not indicative of future performance. This is a marketing communication. It is for informational purposes only. This document does not constitute investment advice or a recommendation to buy, sell or hold any security and shall not be deemed an offer to sell or a solicitation of an offer to buy any security.

    The views and opinions expressed herein, which are subject to change without notice, are those of the issuer or its affiliated companies at the time of publication. Certain data used are derived from various sources believed to be reliable, but the accuracy or completeness of the data is not guaranteed and no liability is assumed for any direct or consequential losses arising from their use. The duplication, publication, extraction or transmission of the contents, irrespective of the form, is not permitted. This material has not been reviewed by any regulatory authorities. In mainland China, it is for Qualified Domestic Institutional Investors scheme pursuant to applicable rules and regulations and is for information purpose only. This document does not constitute a public offer by virtue of Act Number 26.831 of the Argentine Republic and General Resolution No. 622/2013 of the NSC. This communication’s sole purpose is to inform and does not under any circumstance constitute promotion or publicity of Allianz Global Investors products and/or services in Colombia or to Colombian residents pursuant to part 4 of Decree 2555 of 2010. This communication does not in any way aim to directly or indirectly initiate the purchase of a product or the provision of a service offered by Allianz Global Investors. Via reception of this document, each resident in Colombia acknowledges and accepts to have contacted Allianz Global Investors via their own initiative and that the communication under no circumstances does not arise from any promotional or marketing activities carried out by Allianz Global Investors. Colombian residents accept that accessing any type of social network page of Allianz Global Investors is done under their own responsibility and initiative and are aware that they may access specific information on the products and services of Allianz Global Investors. This communication is strictly private and confidential and may not be reproduced, except for the case of explicit permission by Allianz Global Investors. This communication does not constitute a public offer of securities in Colombia pursuant to the public offer regulation set forth in Decree 2555 of 2010. This communication and the information provided herein should not be considered a solicitation or an offer by Allianz Global Investors or its affiliates to provide any financial products in Brazil, Panama, Peru, and Uruguay. In Australia, this material is presented by Allianz Global Investors Asia Pacific Limited (“AllianzGI AP”) and is intended for the use of investment consultants and other institutional /professional investors only, and is not directed to the public or individual retail investors. AllianzGI AP is not licensed to provide financial services to retail clients in Australia. AllianzGI AP is exempt from the requirement to hold an Australian Foreign Financial Service License under the Corporations Act 2001 (Cth) pursuant to ASIC Class Order (CO 03/1103) with respect to the provision of financial services to wholesale clients only. AllianzGI AP is licensed and regulated by Hong Kong Securities and Futures Commission under Hong Kong laws, which differ from Australian laws.

    This document is being distributed by the following Allianz Global Investors companies: Allianz Global Investors GmbH, an investment company in Germany, authorized by the German Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin); Allianz Global Investors (Schweiz) AG; Allianz Global Investors UK Limited, authorized and regulated by the Financial Conduct Authority; in HK, by Allianz Global Investors Asia Pacific Ltd., licensed by the Hong Kong Securities and Futures Commission; in Singapore, by Allianz Global Investors Singapore Ltd., regulated by the Monetary Authority of Singapore [Company Registration No. 199907169Z]; in Japan, by Allianz Global Investors Japan Co., Ltd., registered in Japan as a Financial Instruments Business Operator [Registered No. The Director of Kanto Local Finance Bureau (Financial Instruments Business Operator), No. 424], Member of Japan Investment Advisers Association, the Investment Trust Association, Japan and Type II Financial Instruments Firms Association; in Taiwan, by Allianz Global Investors Taiwan Ltd., licensed by Financial Supervisory Commission in Taiwan; and in Indonesia, by PT. Allianz Global Investors Asset Management Indonesia licensed by Indonesia Financial Services Authority (OJK).

    4265176

Recent insights

Recent years have been disappointing for China equity investors. Markets have pulled back under the weight of macro weakness, the property downturn and geopolitical challenges. We outline 10 reasons why we believe now is the time to reconsider China equities.

Discover more

Navigating Rates

A redrawing of the geopolitical landscape could benefit European markets if the EU is pushed to overhaul defence pending and boost competitiveness.

Discover more

Embracing Disruption

Now we are seeing the rapid development of so called “agentic AI” applications, that are more capable of acting autonomously by analysing information and devising solutions without constant human input. We believe this represents the start of the first big wave of the monetization of AI technology.

Discover more

Allianz Global Investors

You are leaving this website and being re-directed to the below website outside Singapore. This does not imply any approval or endorsement of the information by Allianz Global Investors Singapore Limited contained in the redirected website nor does Allianz Global Investors Singapore Limited accept any responsibility or liability in connection with this hyperlink and the information contained herein. Please keep in mind that the redirected website may contains funds and strategies not authorized for offering to the public of Singapore. Besides, please also take note on the redirected website’s terms and conditions, privacy and security policies, or other legal information. By clicking “Continue”, you confirm you acknowledge the details mentioned above and would like to continue accessing the redirected website. Please click “Stay here” if you have any concerns.

Welcome to Allianz Global Investors

Select your role
  • Individual Investor
  • Intermediaries
  • Institutional Investor
  • It contains legal and regulatory notices relevant to the information contained on this website. By accessing this website, you agree to be bound by the following terms and conditions. Please discontinue your access to this website immediately if you do not accept any of these terms or conditions.


    Investments

    The content of this website is for informational purposes only and does not have any regard to the specific investment objectives, financial situation or particular needs of any particular person.

    Advice should be sought from a financial adviser regarding the suitability of any fund before purchasing units in the fund. In the event that you choose not to seek advice from a financial adviser, you should consider whether the fund is suitable for you. Prices of funds and income from them may fall or rise and cannot be guaranteed.

    Past performance of any fund or manager/ sub-manager of the fund are not necessarily indicative of future performance.

    Prospectuses for funds registered with the Monetary Authority of Singapore under the Authorised Scheme and Recognised Scheme are available, and may be obtained from Allianz Global Investors Singapore Limited or its appointed distributors. Investors should read the prospectuses before investing in such funds.


    No Reliance

    Although Allianz Global Investors Singapore Limited has taken all reasonable care that the information contained within the website is accurate at the time of publication, no representation or warranty (including liability towards third parties), expressed or implied, is made as to its accuracy, reliability or completeness by Allianz Global Investors Singapore Limited or its contractual partners.

    Opinions and any other contents on this website are provided by Allianz Global Investors Singapore Limited for personal use and informational purposes only and are subject to change without notice.

    Nothing contained in the website constitutes investment, legal, tax or other advice nor is to be relied on in making an investment or other decision. You should obtain relevant and specific professional advice before making any investment decision.


    No Warranty

    The information and opinions contained on the website are provided without any warranty of any kind, either expressed or implied, to the fullest extent pursuant to applicable law. Allianz Global Investors Singapore Limited further assumes no responsibility for, and makes no warranties that, functions contained on the website will be uninterrupted or error-free, that defects will be corrected, or that the website or the servers that make it available will be free of viruses or other harmful components.


    Liability Waiver

    Under no circumstances, including , but not limited to, negligence, shall Allianz Global Investors Singapore Limited be liable for any special or consequential damages that result from the access or use of, or the inability to access or use, the materials at the website.


    Linked Sites

    Allianz Global Investors Singapore Limited has not reviewed any websites which link to this website, and is not responsible for the contents of off-site pages linked to from this website or any other websites linked to this website. Following links to any off-site pages or other websites shall be entirely at your own risk.

    The only exception to the above is that Allianz Global Investors Singapore Limited will ensure that all our electronic prospectuses comply with the requirements for electronic prospectuses set out in the Guidelines on Offer of Securities made through the Internet issued by the Monetary Authority of Singapore.


    Copyright

    Copyright to this website is owned by Allianz Global Investors Singapore Limited. The copyrights of third parties are reserved. You may download or print a hard copy of individual pages and/or sections of the website, provided that you do not remove any copyright or other proprietary notices. Any downloading or other copying from the website will not transfer title of any software or material to you. You may not reproduce (in whole or part), transmit (by electronic means or otherwise), modify, hyperlink or use for any public or commercial purpose the website without the prior permission of Allianz Global Investors Singapore Limited.

    All trademarks, service marks and logos on this website are the property of Allianz Global Investors Singapore Limited and other third party proprietors where applicable. Nothing on this website shall be construed as granting any license or right to use any image, trademark, service mark or logo, and Allianz Global Investors Singapore Limited will enforce such rights to the full extent of applicable law.


    Money Laundering

    As a result of money laundering and other regulations, additional documentation for identification purposes may be required when you make your investment.


    Governing Law and Jurisdiction

    These Terms and Conditions governing Allianz Global Investors Singapore Limited's website shall be governed by and construed in accordance with the laws of the Republic of Singapore. By accessing this website's online services, you agree that in relation to any legal action or proceedings arising out of or in connection with these said terms and conditions, you hereby irrevocably submit to the jurisdiction of the courts of the Republic of Singapore.

    Approved for issue by Allianz Global Investors Singapore Limited, 79 Robinson Road, #09-03, Singapore 068897. Company Regn. No. 199907169Z.

    You may face minimal or no returns or suffer total loss of their investments if both the guarantor and the note issuer default.

     

Please indicate you have read and understood the Important Notice.